First Trust Senior Floating Rate Income Fund II
09/19/2024 | Press release | Distributed by Public on 09/19/2024 14:46
Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating[...]
Pharmacokinetics and Serum Virus Neutralizing Antibody Titers Following[...]
Results from a Phase 1 First in human Study of Pemivibart: an[...]
09/19/2024 | Press release | Distributed by Public on 09/19/2024 14:46
Please select the service you want to use:
Smartlinks | First Trust Senior Floating Rate Income Fund II | First Trust Portfolios LP | Finance | Security Markets | Fixed Income | Derivative Securities | Security Markets | Company News | Corporate Debt | Buyback, Treasury Shares and Liquidity Agreements | Financial Services | Investment Services | Closed-End Funds | New York Stock Exchange (NYSE) | NYSE American | NYSE ARCA Equities | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact